Search details
1.
The combination of non-contrast abbreviated MRI and alpha foetoprotein has high performance for hepatocellular carcinoma screening.
Eur Radiol
; 33(10): 6929-6938, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37464111
2.
Response heterogeneity as a new biomarker of treatment response in patients with neuroendocrine tumors.
Future Oncol
; 19(32): 2171-2183, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37497626
3.
The use of deep learning models to predict progression-free survival in patients with neuroendocrine tumors.
Future Oncol
; 19(32): 2185-2199, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37497644
4.
Novel Tumor Growth Rate Analysis in the Randomized CLARINET Study Establishes the Efficacy of Lanreotide Depot/Autogel 120 mg with Prolonged Administration in Indolent Neuroendocrine Tumors.
Oncologist
; 26(4): e632-e638, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33393112
5.
Tumor Growth Rate to Predict the Outcome of Patients with Neuroendocrine Tumors: Performance and Sources of Variability.
Neuroendocrinology
; 111(9): 831-839, 2021.
Article
in English
| MEDLINE | ID: mdl-32717738
6.
Lessons from a multicentre retrospective study of peptide receptor radionuclide therapy combined with lanreotide for neuroendocrine tumours: a need for standardised practice.
Eur J Nucl Med Mol Imaging
; 47(10): 2358-2371, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32062681
7.
Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy - a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocol.
BMC Cancer
; 20(1): 74, 2020 Jan 30.
Article
in English
| MEDLINE | ID: mdl-32000724
8.
The combination of hepatobiliary phase with Gd-EOB-DTPA and DWI is highly accurate for the detection and characterization of liver metastases from neuroendocrine tumor.
Eur Radiol
; 30(12): 6593-6602, 2020 Dec.
Article
in English
| MEDLINE | ID: mdl-32601948
9.
Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET)-The GREPONET Study.
Oncologist
; 24(11): e1082-e1090, 2019 11.
Article
in English
| MEDLINE | ID: mdl-30910869
10.
Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors.
BMC Cancer
; 19(1): 66, 2019 Jan 14.
Article
in English
| MEDLINE | ID: mdl-30642293
11.
Pre-treatment magnetic resonance-based texture features as potential imaging biomarkers for predicting event free survival in anal cancer treated by chemoradiotherapy.
Eur Radiol
; 28(7): 2801-2811, 2018 Jul.
Article
in English
| MEDLINE | ID: mdl-29404766
12.
Contrast-enhanced spectral mammography vs. mammography and MRI - clinical performance in a multi-reader evaluation.
Eur Radiol
; 27(7): 2752-2764, 2017 Jul.
Article
in English
| MEDLINE | ID: mdl-27896471
13.
Concerning CT features used to select patients for treatment of peritoneal metastases, a pictoral essay.
Int J Hyperthermia
; 33(5): 497-504, 2017 08.
Article
in English
| MEDLINE | ID: mdl-28540832
14.
Added Value of Contrast-Enhanced Spectral Mammography in Postscreening Assessment.
Breast J
; 22(5): 520-8, 2016 Sep.
Article
in English
| MEDLINE | ID: mdl-27345656
15.
Diagnostic Performance of MR-guided Vacuum-Assisted Breast Biopsy: 8 Years of Experience.
Breast J
; 22(1): 83-9, 2016.
Article
in English
| MEDLINE | ID: mdl-26511082
16.
Dual-energy contrast-enhanced spectral mammography (CESM).
Arch Gynecol Obstet
; 292(4): 739-47, 2015 Oct.
Article
in English
| MEDLINE | ID: mdl-25814297
17.
Contrast-enhanced spectral mammography: Does mammography provide additional clinical benefits or can some radiation exposure be avoided?
Breast Cancer Res Treat
; 146(2): 371-81, 2014 Jul.
Article
in English
| MEDLINE | ID: mdl-24986697
18.
Prospective evaluation of MR-TRG (Tumor Regression Grade) in esophageal cancer after neo-adjuvant therapy: Preliminary results.
Eur J Radiol
; 171: 111263, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38159523
19.
Anatomical Quantitative Volumetric Evaluation of Liver Segments in Hepatocellular Carcinoma Patients Treated with Selective Internal Radiation Therapy: Key Parameters Influencing Untreated Liver Hypertrophy.
Cancers (Basel)
; 16(3)2024 Jan 30.
Article
in English
| MEDLINE | ID: mdl-38339337
20.
Clinical management of typical and atypical carcinoids/neuroendocrine tumors in ENETS centres of excellence (CoE): Survey from the ENETS lung NET task force.
J Neuroendocrinol
; : e13412, 2024 May 16.
Article
in English
| MEDLINE | ID: mdl-38754956